Shared and Distinct Functions of Type I and Type III Interferons

被引:767
|
作者
Lazear, Helen M. [1 ]
Schoggins, John W. [2 ]
Diamond, Michael S. [3 ,4 ,5 ,6 ]
机构
[1] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA
[2] Univ Texas Southwestern Med Ctr Dallas, Dept Microbiol, Dallas, TX 75390 USA
[3] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA
[4] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA
[5] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA
[6] Washington Univ, Sch Med, Andrew M & Jane M Bursky Ctr Human Immunol & Immu, St Louis, MO 63110 USA
关键词
CHRONIC HEPATITIS-C; REGULATORY FACTOR FAMILY; T-CELL RESPONSES; IFN-LAMBDA; ZIKA VIRUS; ADJUVANT THERAPY; PEGINTERFERON ALPHA-2A; STIMULATED GENES; PEGYLATED INTERFERON-ALPHA-2B; ANTIVIRAL PROTECTION;
D O I
10.1016/j.immuni.2019.03.025
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Type I interferons (IFNs) (IFN-alpha,IFN-beta) and type III IFNs (IFN-lambda) share many properties, including induction by viral infection, activation of shared signaling pathways, and transcriptional programs. However, recent discoveries have revealed context-specific functional differences. Here, we provide a comprehensive review of type I and type III IFN activities, highlighting shared and distinct features from molecular mechanisms through physiological responses. Beyond discussing canonical antiviral functions, we consider the adaptive immune primin anti-tumor, and autoimmune functions of IFNs. We discuss a model wherein type III IFNs serve as a front-line defense that controls infection at epithelial barriers while minimizing damaging inflammatory responses, reserving the more potent type I IFN response for when local responses are insufficient. In this context, we discuss current therapeutic applications targeting these cytokine pathways and hignlignt gaps in understanding of the biology of type I and type III IFNs in health and disease.
引用
收藏
页码:907 / 923
页数:17
相关论文
共 50 条
  • [41] Comparison of the Regulation of β-Catenin Signaling by Type I, Type II and Type III Interferons in Hepatocellular Carcinoma Cells
    Li, Wei
    Huang, Xiaojie
    Tong, Hongfei
    Wang, Yuxuan
    Zhang, Tong
    Wang, Wen
    Dai, Lili
    Li, Tongzeng
    Lin, Shengzhang
    Wu, Hao
    PLOS ONE, 2012, 7 (10):
  • [42] The crosstalk between β-catenin signaling and type I, type II and type III interferons in lung cancer cells
    Bai, Ming
    Li, Wei
    Yu, Nanze
    Zhang, Hailin
    Long, Fei
    Zeng, Ang
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2017, 9 (06): : 2788 - 2797
  • [43] ANTAGONISM AND SYNERGISM BETWEEN TYPE-I AND TYPE-II INTERFERONS ON MACROPHAGE FUNCTIONS
    GAROTTA, G
    POLAK, AM
    TALMADGE, KW
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 1987, 25 (02) : C3 - C3
  • [44] Regulation of apoptosis by type III interferons
    Li, W.
    Lewis-Antes, A.
    Huang, J.
    Balan, M.
    Kotenko, S. V.
    CELL PROLIFERATION, 2008, 41 (06) : 960 - 979
  • [45] Microbial pathogenesis and type III interferons
    Cohen, Taylor S.
    Parker, Dane
    CYTOKINE & GROWTH FACTOR REVIEWS, 2016, 29 : 45 - 51
  • [46] Type I Interferons as Regulators of Human Antigen Presenting Cell Functions
    Gessani, Sandra
    Conti, Lucia
    Del Corno, Manuela
    Belardelli, Filippo
    TOXINS, 2014, 6 (06): : 1696 - 1723
  • [47] Type I Interferons: Distinct Biological Activities and Current Applications for Viral Infection
    Li, Shi-fang
    Gong, Mei-jiao
    Zhao, Fu-rong
    Shao, Jun-jun
    Xie, Yin-li
    Zhang, Yong-guang
    Chang, Hui-yun
    CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2018, 51 (05) : 2377 - 2396
  • [48] Type III Interferons (Lambda Interferons) in Rheumatic Autoimmune Diseases
    Mora-Arias, Tania
    Amezcua-Guerra, Luis M.
    ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS, 2020, 68 (01)
  • [49] Type III Interferons (Lambda Interferons) in Rheumatic Autoimmune Diseases
    Tania Mora-Arias
    Luis M. Amezcua-Guerra
    Archivum Immunologiae et Therapiae Experimentalis, 2020, 68
  • [50] Distinct contributions of Type I and Type III IFNs in innate fungal immunity
    Espinosa, Vanessa
    Dutta, Orchi
    Mc Elrath, Constance
    Du, Peicheng
    Chang, Yun-Juan
    Cicciarelli, Bryan
    Pitler, Amy
    Whitehead, Ian
    Obar, Joshua J.
    Durbin, Joan
    Kotenko, Sergei
    Rivera, Amariliz
    JOURNAL OF IMMUNOLOGY, 2020, 204 (01):